LivingGLP1
Study S003287

A Pharmacokinetic Study of HDM1005 Injection at Different Injection Sites

Registration

Registration
NCT07828197
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
NONE
Status
ACTIVE_NOT_RECRUITING
Enrollment
135
Start
2026-09-03
Primary completion
2026-10
Lead sponsor
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions
Overweight and/or Obesity; Healthy Participants
Interventions
DRUG:HDM1005
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Cmax [Up to Day 29]
  • AUC(0-t) [Up to Day 29]
  • AUC(0-∞) [Up to Day 29]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.